Cryotherapy of the Uterine Cervix
 

E.J. Mayeaux, Jr., M.D.
Professor of Family Medicine
Professor of Obstetrics and Gynecology
Louisiana State University Health Sciences Center - Shreveport, LA





Introduction

Cryotherapy is a time proven ablative method of treating lower grades of cervical dysplasia. Women who need cryotherapy typically have had an abnormal Pap smear which has led to colposcopy, biopsy, and a diagnosis of cervical dysplasia. The procedure is easy to learn and perform and can easily be applied in outpatient settings.



Equipment

The device consists of a gas tank containing non-explosive, non-toxic gases (usually nitrous oxide but may be carbon dioxide). 1, 2 A 20 lb gas cylinder is preferable to the 6 lb "E" type tank since it has a more efficient pressure release curve. 2 Liquid nitrogen has been used in the past but is difficult to control and is not currently recommended. 9 The regulator usually contains a gas cut-off and a pressure gage. The refrigerant is delivered via flexible tubing through a gun-type unit to the cryoprobe. Cryoprobe should be disinfected between uses, usually by chemical methods.



Theory

The cryoprobe is cooled by the Joule-Thomson effect. The refrigerant gas is fed into the hollow cryoprobe under pressure. The gas then rapidly expands and absorbs heat in the process. This reduces the temperature of the probe of nitrous oxide based units to -65 to -85 degrees Centigrade. The cryoprobe then acts as a heat-sink and removes heat from the cervical tissue. 2

After the cryoprobe is placed in contact with the cervix and activated, a ring of frozen tissue or "iceball" rapidly moves outward. The depth of freeze approximates the lateral spread of the freeze. Most of the tissue in this zone will necrose. However there is a ring of tissue (the thermal injury or recovery zone) that freezes but doesn’t reach the -20 degrees necessary for cell death. 3 This is why it is necessary to freeze well beyond the margins of any lesions.

Studies have demonstrated that endocervical crypt (gland) involvement of cervical intraepithelial neoplasia (CIN) may penetrate up to 3.8mm into the cervix. 4 Therefore, a freeze that causes cell death to 4mm will effectively eradicate 99.7% of lesions with gland involvement. Current recommendations are to produce an iceball with a 5mm lateral spread to accomplish this goal.

A water soluble lubricant is applied to the probe to act as a thermocouple with the irregular surface of the cervix. 1 This produces a more uniform freeze. A rapid freeze followed by a slow thaw maximizes cryonecrosis. 2, 5 A freeze-thaw-refreeze cycle is also more effective than a single freeze. 2, 6, 7, 1, 8



Indications:
Only indicated for the treatment of biopsy-proven squamous dysplasia after an adequate colposcopic exam. It may be used to treat HPV on the external genitalia for cosmetic purposes (using different freezing protocols than for treating the uterine cervix). 1

Often reserved for CIN 1 and 2 level lesions. There may be a higher recurrence rate compared to LEEP for CIN 3 level lesions, possibly due to the greater depth of glandular involvement with CIN 3. 8 -11

Indicated for disease limited to a small area of cervix that is easily visible in its entirety. The cryotherapy probe must be able to cover the entire transformation zone and the entire lesion for the therapy to be most effective.



Contraindications:
Advantages (Benefits):
Disadvantages (Risks):
How to Perform Cryotherapy
Problems During the Procedure:

The most common minor complication to occur is for the probe to touch the vaginal side wall and to adhere to it. This will cause pain. The operator may quickly push the vaginal mucosa off the probe with a tongue blade. If this is not done quickly it will become more difficult as the freeze deepens, and more vaginal mucosa will be destroyed. The operator should defrost the probe just enough to release the side-wall and then continue the freeze. Slight bleeding may occur from the injured vaginal mucosa. Occasionally a tongue blade placed along each side wall as a barrier is the only way to prevent unwanted contact between the probe and the vagina.

A second possible problem is an asymmetric freeze on the face of the cervix. Changing probes or freezing in segments will usually solve this problem.

Occasionally a patient may experience an undue amount of pain and cramping, usually associated with a high level of anxiety. If this can be anticipated, a paracervical block prior to cryotherapy, IM benzodiazapines (ie 1mg Ativan IM) or IV sedation may be chosen for relief. These measures will rarely be required. Rarely a patient may have a vasovagal reaction. Allow the patient to rest on the examination table after the procedure and to get up slowly is usually sufficient to overcome this problem.


Aftercare and Follow-up:

Most patients experience a heavy and often odorous discharge for the first month after cryotherapy. This discharge results from the sloughing of dead tissue and exudate from the treatment site. Some physicians recommend debridernent of the eschar to decrease the discharge although this has not been proven to be effective. Aminocerv cream may be prescribed if a heavy discharge is present post-procedure.

The patient should refrain from sexual intercourse and tampon use for 3 weeks after cryotherapy to allow the cryotherapy bed time to reepithelialize. Excessive exercise should likewise be discouraged to lessen the chance of post-therapy bleeding. 9, 19

The first follow-up Pap should be done in 3 to 6 months. A Pap smear is of no value during the sloughing or regenerative phases which takes at least 3 months to complete. If this and the following smears are normal, Pap smears should be repeated every six months for two years from treatment. Most recurrences will occur within 2 years of treatment. 9 Yearly smears may be recommended after that. An alternative method involves replacing the initial and each yearly Pap smear with a colposcopic examination. If any of the follow-up tests are positive, restart the work-up as if there was a new, first-time dysplasia.

If a follow-up Pap smear is abnormal, a colposcopy with directed biopsy is usually performed. Unfortunately, colposcopy may be more difficult due to migration of the squamocolumnar junction deeper into the cervical os. Other treatment methods (usually LEEP) are preferred if persistent disease is discovered.


Click here for selected outcome studies of cryotherapy for the treatment of cervical dysplasia from the English language literature.
Click here for physician charges for treatments for cervical dysplasia.



References 1. Creaseman WT, Henshaw WM, Clarke-Pearson DL. Cryosurgical in the management of cervical intraepithelial neoplasia. Obstet Gynecol 1984; 63:145-9.
2. Ferris DG, Ho JJ. Cryosurgical equipment: A critical review. J Fam Pract 1992; 35:185-93.
3. Zacarian SA. Is lateral spread of freeze a valid guide to depth of freeze? J Dermatol Surg Oncol 1978; 4:561-3.
4. Anderson MC, Hartley RB. Cervical crypt involvement by intraepithelial neoplasia. Obstet Gynecol 1990; 55:546-50. Glands
5. Townsend DE. Cryosurgery. Surg Clin North Am 1978; 58:97-108.
6. Creaseman WT, Weed JC Jr, Curry SL, Johnston WW, Parker RT. Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia. Obstet Gynecol 1973; 4:501-6. Efficacy
7. Kaufman RH, Conner JS. Cryosurgical treatment of cervical dysplasia. Am J Obstet Gynecol 1971; 109:1167-74.
8. Bryson SCP, Lenehan P, Lickrish GM. The treatment of grade 3 of cervical intraepithelial neoplasia with cryotherapy: An 11-year experience. Am J Obstet Gynecol 1985; 151:201-6.
10. Tredway DR, Townsend DE, Hovland DN, Upton RT. Colposcopy and cryosurgery in cervical intraepithelial neoplasia. Am J Obstet Gynecol 1972; 114:1020-4.
11. Ostergard DR. Cryosurgical treatment of cervical intraepithelial neoplasia. Obstet Gynecol 1980; 56:231-3.
12. Kaufman RH, Strama T, Norton PK, Conner JS. Cryosurgical treatment of cervical intraepithelial neoplasia. Obstet Gynecol 1973; 42:881-6.
13. Draeby-Kristiansen J, Grasaae M, Bruun M, Hansen K. Ten years after cryosurgical treatment of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1991; 165:43-5.
14. Anderson ES, Husth M. Cryosurgery for cervical intraepithelial neoplasia: 10-year follow-up. Gynecol Oncol 1992:45:240-2.
15. Rodney WM, Huff M, Euans D, Hutchins C, Clement K, MaCall JW. Colposcopy in family practice: Pilot of pain prophylaxis and patient volume. Fam Pract Res J 1992; 12:91-8.
16. Sammarco MJ, Hartenbach EM, Hunter VJ. Local anesthesia for cryosurgery of the cervix. J Reprod Med 1993; 38:170-2.
17. Rogstad KE, White DJ, Ahmed-Jushuf. Efficacy of lidocaine analgesia during treatment of the cervix. Lancet 1992; 340:942.
18. Benedet JL, Miller DM, Nickerson KG, Anderson GH. The results of cryosurgical treatment of cervical intraepithelial neoplasia at one, five, and ten years. Am J Obstet Gynecol 1987; 157:268-73.
19. Crisp WE. Cryosurgical treatment of neoplasia of the uterine cervix. Obstet Gynecol 1972; 39:495-9.
20. Crisp WE, Smith MS, Asadourian LA, Warrenburg CB. Cryosurgical treatment of premalignant disease of the uterine cervix. Obstet Gynecol 1970; 107:737-42.
21. Charles EH, Savage EW. Cryosurgical treatment of cervical intraepithelial neoplasia: analysis of failures. Gynecol Oncol 1980; 9:361.
22. Popkin DR, Scali V, Ahmed MN. Cryosurgery for the treatment of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1978; 130:551-4.
23. Richart M, Townsend DE, Crisp W. DePetrillo A, Ferenczy A, Johnson G, et al. An analysis of "long-term" follow-up results in patients with cervical intraepithelial neoplasia treated by cryosurgery. Am J Obstet Gynecol 1980; 137-823-6.
24. Hellberg D, Nilsson S. 20-year experience of follow-up of the abnormal smear with colposcopy and histology and treatment by conization or cryosurgery. Gynecol Oncol 1990; 38:166-9.

Return to LSUHSC-S Family Medicine Home Page

Return to the LSUHSC-S Home Page.